ALK-Abelló A/S (OTC:AKBLF) Trading 1.4% Higher – Should You Buy?

ALK-Abelló A/S (OTC:AKBLFGet Free Report)’s share price was up 1.4% during trading on Monday . The company traded as high as $20.59 and last traded at $20.59. Approximately 5 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 300 shares. The stock had previously closed at $20.30.

ALK-Abelló A/S Price Performance

The firm’s 50-day simple moving average is $20.91 and its two-hundred day simple moving average is $22.73.

ALK-Abelló A/S Company Profile

(Get Free Report)

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.

Read More

Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.